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Introduction
Severe Combined Immunodeficiency (SCID) caused by deficiency 
of the common cytokine receptor gamma chain (γc) is character-
ized by defective T and NK cell development, resulting in life- 
threatening infections. Although the condition can be cured by 
bone marrow transplantation (BMT) or gene therapy, several 
long-term complications are seen; in particular a high incidence 
of severe cutaneous human papilloma virus (HPV) infection that 
suggests residual defects of immunity1–3. HPV susceptibility 
is not predicted by transplantation conditions or subsequent 
immune reconstitution, but is curiously restricted to SCID 
resulting from mutations in γc or its signaling mediator Janus- 
associated kinase 3 (JAK3) and therefore appears to be related 
to the original genetic mutation.
HPV infections are limited to the epidermis suggesting 
persistent defects in the skin compartment, which could relate 
to keratinocytes or hematopoietic-derived immune cells. As 
many SCID patients receive BMT without any chemotherapy 
conditioning, B cell and myeloid lineages remain of host origin 
and therefore γc-deficient in the majority of cases1,2. This includes 
antigen-presenting dendritic cells (DC) derived from bone 
marrow, such as dermal (migratory) DC4 and those that self- 
renew in tissues, such as epidermal Langerhans cells (LC). 
Although the mechanisms are poorly understood, LC and 
dermal DC are predicted to be important for regression of 
cutaneous HPV lesions through their role as potent skin antigen 
presenting cells for priming adaptive immune responses5,6. It is 
thought that CD4+ T cells also play a central role in anti-
HPV immunity, as their presence at sites of HPV infection are 
predictive of clearance, while susceptibility to HPV infection is 
dramatically increased by CD4+ T cell immunodeficiency7–11. 
Since γc-deficiency in T cells is effectively corrected in 
SCID patients who have undergone BMT, we speculated that 
γc-deficient residual DC might be defective in priming antigen- 
specific CD4+ T cells in these patients, and hence might contribute 
to the observed impaired immunity to infection.
As ex vivo isolation of primary LC and dermal DC populations 
in large numbers is technically challenging, we modeled DC 
γc-deficiency using monocyte-derived DC generated from the 
bone marrow of γc-deficient mice. While DC subsets differ in 
specific functions that likely relate to the particular require-
ments of their tissue environments, all myeloid-derived DC 
populations share prototypical features, including antigen uptake, 
presentation and T cell priming4. DC/LC normally express 
several γc-containing cytokine receptors: specifically IL-2R, 
IL-4R, IL-15R and IL-21R that, upon binding their respective 
cytokines, regulate DC functions such as activation and cytokine 
release12. In addition, DC-expressed IL-15R (and possibly 
IL-2R) regulates the function of other immune cells through the 
unusual mechanism of cytokine transpresentation that requires 
direct intercellular interaction13–15. In particular, transpresenta-
tion of IL-15 by DC is required for NK cell and memory CD8+ 
T cell activation and homeostasis13,16. Although several studies 
have shown that IL-15 enhances CD4+ T cell proliferation and is 
required for CD4+ memory homeostasis17–22 the importance of 
transpresentation for IL-15-dependent T-cell functions has not 
been clear until recently when effector CD4+ T-cell differentiation 
was shown to rely on transpresented rather than soluble IL-1523. 
To date, this has not been further detailed at a mechanistic 
level and a role for DC-mediated IL-15 transpresentation in 
CD4+ T-cell activation has not been documented.
In this study, we investigate the role of γc in DC function and 
identify a defect in the ability of γc-deficient DC to prime naïve 
CD4+ T cells. Using a novel supported planar bilayer sys-
tem that mimics key molecular features of the T cell surface, 
we demonstrate that, independent of its signaling function, 
DC-expressed γc localises to the DC:T-cell contact interface fol-
lowing MHCII ligation and results in recruitment and colocaliza-
tion of IL-15Rα with MHCII. We show that γc-deficiency in DC 
critically impairs IL-15Rα recruitment and IL-15 transpresenta-
tion to naïve CD4+ T cells at the immunological synapse, result-
ing in incomplete T cell activation. In light of these findings, we 
suggest a novel model for IL-15 transpresentation in which the 




Mice were C57BL/6 wild-type and OTII transgenic (OVA323–339 
peptide (pOVA)/I-Ab-specific CD4+ T cells) (Charles River, 
Kent, UK). γc/Rag2-/- mice (C57BL/6) were kindly provided by 
Dr. Colucci (Babraham Institute, Cambridge, UK). Male and 
female mice were housed in individually ventilated cages, up 
to 6 mice per cage with bedding changed twice weekly and 
sacrificed by exposure to a rising concentration of C02 at 8–12 
weeks of age weighing approximately 25–30g. Bone marrow 
was extracted from tibia and femur bones. Work in mice was 
performed in an ethical manner according to UK Home Office 
regulations under project licence number PPL 70/7329.
Cloning procedures
The lentiviral construct encoding γcWT-GFP fusion protein (pLV-
CMVEI.hIL2RG-SceI-EGFPds) was kindly provided by Nadine 
Dannemann, Toni Cathomen Lab, Hannover Medical School. 
A truncated γcΔc-GFP was created by introduction of AgeI site 
by PCR with following primers: forward primer (GAAGACA 
CCGACTCTAGAGCCACCATGTTG), reverse primer (CAA 
CCGGTGGGCATCGTCCGTTCCAG). The PCR product was 
digested with XbaI and AgeI and religated into the original 
vector to create a γcΔc-GFP fusion lacking 77 amino acids at the 
C terminus.
Cell isolation and culture
Bone marrow-derived DC (BMDC) were generated, LPS-matured 
and OVA-pulsed as previously described24. BMDC were blocked 
for 30 min at 37°C with anti-IL-15Rα (AF551) or isotype-
matched controls (both R&D Systems, 20μg/ml unless otherwise 
stated). DC were nucleoporated with 5μg lentiviral plasmid DNA 
using the Amaxa Mouse Dendritic Cell Nucleofector Kit 
(Lonza). Unsorted cells were used for experiments. Splenic 
CD4+ T cells were isolated using a negative selection magnetic 
bead isolation kit (Miltenyi Biotech). For proliferation experi-
ments, CD4+ T cells were labeled with 5μM CFSE dye for 20 min 
at 37°C then washed before co-culture.
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ELISA and flow cytometry assays
Supernatants of LPS-stimulated DC were assayed for IL-1β, 
IL-10, IL-12 using the Beadlyte® system (Millipore) and for 
IL-6 and TNF-α on ELISA (eBioscience). IL-2 secretion by 
CD4+ T cells was analysed with mouse IL-2 ELISA kit (R&D 
Systems). pSTAT5 assays were performed as previously 
described25 using serum-starved CD4+ T cells co-cultured at 
1:1 ratio for 10 min at 37°C with DC. Antibodies used for flow 
cytometry were against CD16/CD33 (2.4G2), CD86 (GL1), 
CD11c (HL3), CD4 (RM 4-5, SK3), I-A/I-E (2G9), pSTAT5 
(pTyr694; clone 47) (all BD Biosciences), IL-15Rα (AF551) 
(R&D systems) and against γc (M-20) and IL-15 (H-114) (both 
from Santa Cruz Biotechnology). Apoptosis was assessed using the 
AnnexinV Apoptosis Detection Kit (BD Biosciences).
Antigen uptake and presentation assays
Uptake and breakdown of DQ-OVA (self-quenched fluorescent 
conjugate of ovalbumin, Molecular Probes, Invitrogen), meas-
ured as emission of green fluorescence (515nm), were assessed 
as previously described24. For measurement of antigen presen-
tation, DC were matured overnight with LPS in the absence or 
presence of the indicated concentrations of Eα -GFP protein 
(kindly provided by Dr. Paul Garside, University of Glasgow). 
Eα peptide presentation was measured after 24hrs by flow 
cytometry. Briefly, cells were stained with antibodies against 
CD11c, IA/IE and the biotinylated Yae (specific for Eα 52-68 peptide 
presented on I-Ab) antibody (eBioscience) followed by strepta-
vidin. DC were gated as CD11c+IA/IEhi cells and presenta-
tion of Eα calculated as an index relative to DC matured in the 
absence of Eα -GFP (LPS only) using the following equation: 
100 × (logEa/logLPS) – logLPS. For measurement of antigen pres-
entation, DC were pulsed overnight with varying concentrations 
of OVA in the presence of LPS then co-cultured for 48hrs at a 
1:5 ratio with BO17.4 hybridoma cells. IL-2 secretion by 
BO17.4 cells was measured by ELISA.
Planar lipid bilayers
Liposome stocks containing DOPC, 25 mol% DGS-NTA and 
2 mol% Cap-biotin (Avanti Polar Lipids) were prepared as 
described elsewhere26. To make glass-supported planar bilayers 
for DC imaging, liposomes were mixed in appropriate ratios to 
produce DOPC bilayers with 0.01 mol% Cap-biotin and 12.5% 
DGS-NTA. Following washing with HBS containing 1% human 
serum albumin, 1mM Ca and 2mM Mg (HBS/HSA), bilayers 
were blocked with 5% Casein containing 100μM NiCl2, and 
incubated with 5μg/ml strepatavidin in HBS/HSA for 15min, 
and following washing, incubated for a further 30 min with a 
mixture of LFA-I domain-His6 (10μg/ml) and monobiotinylated 
anti-I-A/E Fab’ fragments (5ug/ml). Further details of anti-I-
A/E, LFA and ICAM protein preparations are available in the 
Supplemental material). For imaging of OTII T cells, DOPC 
bilayers were prepared as above, containing 12.5% DOGS-NTA. 
ICAM-his12 and I-Ab/OVA-his12 were added to bilayers to yield 
densities of 300 mol/μm2 and 100 mol/μm2 respectively. DOPC 
liposomes containing CD80 were incorporated at 200 mol/μm2. 
Soluble IL-15/IL-15Rα with a C-terminal 6-histidine tag 
(eBioscience) was incorporated (2μg/ml) as indicated.
Microscopy
TIRF imaging was performed using a Nikon Ti microscope 
equipped with a 100x Nikon TIRF objective, NA 1.49. Cells 
interacting with bilayers were fixed with 2% PFA; permeabilised 
with 0.1% saponin and quenched with 50mM glycine; blocked 
and stained with pSTAT5 (D47E7) (Cell Signaling) or IL-15Rα 
(H-107) (Santa Cruz Biotechnology). Secondary antibodies used 
were anti-rabbit AlexaFluor488 (Molecular Probes, Invitrogen). 
Measurement of labeled molecules was achieved by determin-
ing fluorescence intensity within regions of cell contact identified 
either using a threshold on TCR intensity (pSTAT5) or by the 
IRM channel (IL-15Rα). For analysis of MHCII and GFP accu-
mulation at DC interfaces, fluorescence intensities were acquired 
at 4 frames/min over 25-min. Data were analysed with the 
Metamorph and ImageJ software. Please see Supplementary 
File 1 for more details on imaging methodology.
Imaging of DC on lipid bilayers
Tracking of DC by confocal imaging was performed at 37°C 
in a heated environmental chamber. LPS/OVA-stimulated DC 
were introduced into flow-cells and areas of bilayers, selected 
at random, imaged for 37–45 min at 15 sec intervals. DIC and 
reflection (IRM) channels were recorded (+/- AF568 fluores-
cence) using appropriate laser excitation and emission filters. Cells 
were tracked manually in ImageJ software using cell nuclei in 
DIC images as a position reference. For quantitation of fluo-
rescence intensities at DC interfaces with planar bilayers by 
TIRFM, cell contacts in the central region of the TIRF field, 
which is more evenly illuminated than the edges, were analyzed to 
minimize variations due to the inherent curvature of TIRF mode 
illumination. To estimate the extent to which variations in TIRF 
illumination contributed to the observed differences in meas-
urements of specific fluorescence, the anti-MHC II Fab’ AF568 
fluorescence intensity in bilayer regions immediately adjacent 
to DC interfaces was measured for all interfaces from which IL- 
15Rα fluorescence intensity was quantitated. Since non-interface 
anti-MHC II Fab’ AF568 is evenly distributed on bilayers, its 
fluorescence effectively represents laser excitation, in TIRF 
mode, within the imaging field. The morphology of the TIRF 
field was comparable between fluorescence channels. This 
baseline anti-MHC II Fab’ AF568 fluorescence was used to 
estimate the contribution of inter-sample (between γc-/- and WT 
DC samples) variation in TIRF illumination in interface fluores-
cence intensity measurements. Colocalization between engaged 
MHC II and IL-15Rα at DC interfaces was measured using 
Pearson correlation coefficient (PCC). To rule out spurious 
differences in PCC due to lower IL-15Rα fluorescence intensity 
at γc-/- DC interfaces, PCC between MHC II and IL-15Rα was 
calculated for a subset of γc-/- and WT interfaces with comparable 
IL-15Rα fluorescence intensity.
Intracellular Ca2+ imaging
Bilayers containing LFA-1 Iα with or without anti-MHCII Fab’ 
fragments were made in FCS II flow cells as described above. 
Prior to introduction of DCs, flow cells were equilibrated to 
37°C in the heated environmental of an LSM510 confocal 
microscope. DCs were loaded with 3 μM Fluo-4 AM (Invitrogen) 
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for 20 min in serum free media, washed, and incubated for a 
further 20 min in complete cell culture media. Cells were 
subsequently washed, resuspended in HBS/HSA and introduced 
into flow chambers for confocal imaging using a 20x, NA 0.75 
air objective, and wide confocal iris settings. All imaging was 
performed at 37°C, and images acquired for Fluo-4 and DIC 
channels every 15 seconds for ~25 minutes. Cell tracking and 
mean Flou-4 flourescence was measured using ImageJ.
Statistics
Prism v.5 (GraphPad Software) was used for statistical analysis. 
This included two-tailed Student’s t-test with 95% confidence 
bounds, one-way ANOVA (with Bonferroni’s correction for 
multiple comparison), Gaussian curve-fitting was performed 
with single, bimodal, and trimodal model parameters.
Results
γc-/- DC fail to trans-present IL-15 during antigen specific 
activation of naïve CD4+ T cells
To investigate the role of γc in DC function, we gener-
ated conventional bone marrow-derived DC (BMDC) from 
γc-deficient (γc-/-) mice27. These mice also lack lymphoid-restricted 
recombinase activating gene 2 (RAG 2) by genetic modifica-
tion, to eliminate low levels of persisting T cells seen in γc single 
knockout strains28. Deletion of RAG 2 does not impair the 
function of GMCSF-derived BMDC29 consistent with a lack of 
expression of VDJ rearrangement genes and RAG transcripts in 
conventional DC30.
As expected, BMDC derived from γc-/- mice completely lacked 
γc protein expression and γc-dependent cytokine signaling 
(Figure S1A,B) but expressed MHCII and the costimulatory 
molecule CD86 at levels comparable with WT DC both in 
the immature state and following LPS-induced maturation 
(Figure S1C). To test whether γc-/- DC support normal antigen- 
mediated priming of T cells, DC were pulsed with whole 
ovalbumin (OVA) that is internalized, processed and presented 
on the surface of DC as a peptide antigen (pOVA) in complex 
with the class II MHC molecule I-Ab. When co-cultured 
with OTII CD4+ T cells, transgenic for a TCR recognising 
pOVA/I-Ab, OVA–pulsed γc-/- DC induced a moderate but 
significantly lower level of T cell proliferation than WT DC 
(p≤0.05, Figure 1A,B) and markedly reduced IL-2 secretion 
(p≤0.05, Figure 1C). As previously described31, under these 
conditions, IL-2 release by DC was negligible (Figure S1D) 
indicating that the impairment was due to defective T cell 
activation. Taken together, these data show that DC-expressed γc 
is required for full activation of antigen-specific CD4+ T cells.
Our findings were not due to impaired antigen uptake, process-
ing or presentation of surface MHC/antigen complexes as γc-/- DC 
were as efficient as WT DC at internalising and processing DQ™ 
ovalbumin (Figure S1E) and at processing and presenting the 
model Eα antigen (Figure S1F,G). Furthermore, OVA-pulsed 
mature γc-/- and WT DC induced similar levels of IL-2 release 
from the B017.4 T cell hybridoma (which expresses the OTII TCR 
and is less dependent on costimulation) (Figure S1H), demon-
strating that pOVA presentation by surface MHC molecules was 
functionally similar between WT and γc-/- DC. Together, these 
data demonstrate that the observed defects in γc-/- DC mediated 
CD4+ T cell activation are not explained by defective antigen 
handling. As mature γc-/- and WT DC released similar levels 
of pro-inflammatory cytokines such as IFN-β, IL6, IL-12 and 
TNF-α (Figure S1I), we reasoned that the observed defect of 
T-cell activation was due to a contact dependent rather than a 
soluble messenger mechanism.
As it is known that optimal naïve T cell activation depends on 
stable adhesion to DC32, we investigated whether γc-deficiency 
impaired T-DC intercellular adhesion. Both conjugate- 
formation and redistribution of LFA-1 to the IS, a hallmark 
of T cell polarisation in response to antigen recognition33, were 
preserved in T cells co-cultured with γc-/- DC (Figure S2A–C). 
Taken together, these data demonstrate that the defective anti-
gen-specific T cell priming observed in γc-/- DC is not due to 
impaired adhesion or LFA-1/ICAM-1 dependent T cell polariza-
tion. We further examined the fine-structure of the T-DC contact 
interface using transmission electron microscopy. Binding of 
TCR to pMHC occurs at, and stabilises, regions of close contact 
(~12 nm apart) between apposed membranes at T-DC interfaces, 
which are thought to be critical for signaling34,35. Compared to 
WT DC interfaces, γc-/- DC formed a similar proportion of close 
contacts with T cells, interspersed between areas of greater 
membrane separation (~30–50 nm)(Figure S2D–G), demonstrat-
ing that antigen-induced close contacts were preserved in the 
absence of γc.
Since antigen presentation, adhesion, secretory, and canonical 
costimulatory functions appeared to be preserved in γc-/- DC, 
we considered other plausible defects in DC function that might 
account for incomplete T cell priming. One candidate for this is 
the delivery of IL-15 mediated stimulatory signals to T cells by 
transpresentation. While it is well established that DC transp-
resent IL-15 to CD8+ T cells and NK cells36,37, the role of 
IL-15 transpresentation in CD4+ T cell activation has only begun 
to be explored23. To further establish whether IL-15 transpresen-
tation occurs during DC-CD4+ T cell interactions, we analysed 
STAT5 activation in OTII T cells after 10 minute co-culture with 
LPS-matured WT DC. We observed that significant induction of 
STAT5 phosphorylation in CD4+ T cells occurred only when DC 
had been pre-loaded with antigen (p≤0.05, Figure 1D,E). Pre- 
treatment with an IL-15 blocking (Figure 1D,E), but not an IL-2 
blocking (Figure S3A,B), monoclonal antibody abolished STAT5 
phosphorylation in OTII T cells indicating that STAT5 activa-
tion occurs primarily through IL-15 transpresentation during 
DC-mediated priming of naïve CD4+ T cells in our experimental 
system.
Notably, antigen-pulsed γc-/- DC were severely compromised in 
their ability to activate STAT5 in OTII T cells, compared with 
WT DC (Figure 1D,E), strongly implicating a role for γc in IL-15 
transpresentation by DC. T cell proliferation induced by antigen- 
pulsed WT DC was also inhibited by IL-15Rα blockade in a 
dose-dependent manner. Consistent with the notion that naïve 
CD4+ T cell priming by γc-/- DC is compromised primarily due 
to defective IL-15 transpresentation, the reduced antigen-specific 
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Figure 1. γc-/- DC fail to transpresent IL-15 to CD4+ T cells during antigen-specific priming. (A) Representative plots showing CFSE 
dilution in CD4+-gated OTII T cells after co-culture with LPS-matured OVA-pulsed DC for 72 hrs. Grey dotted histograms represent CD4+ 
T cells cultured with DC in the absence of antigen. (B) Quantification of T cell proliferation shown in A. (C) IL-2 release by CD4+ T cells 
incubated with OVA-pulsed DC at the indicated ratios for 72hrs. (D) pSTAT5 induction in CD4+ T cells following a 10 minute incubation with 
DC, either untreated or stimulated overnight with LPS ± OVA. DC were blocked with anti-IL-15Rα or isotype control. (E) Increase in pSTAT5 
fluorescence (D), compared to unstimulated control. (F) Inhibition of CD4+ T cell proliferation after co-culture for 72hr with OVA-pulsed DC 
pre-treated with anti-IL-15Rα (relative to isotype-matched control antibody treatment). (G) Total and surface IL-15Rα expression (FAB551F) 
on CD11c gated cells. (H) Schematic of construct encoding full length (γcWT-GFP) and truncated (γcΔc-GFP) γc attached to GFP. (I) Increase 
in pSTAT5 levels, compared to unstimulated control, in CD4+ T cells following incubation with DC ±OVA, transfected withγcWT-GFP, γcΔc-GFP 
or ctrl GFP. P values, t-test (B,C,I) ; one-way ANOVA (E); linear regression (p value tests for significant difference between the slope of each 
line) (F).
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proliferative response of naïve CD4+ T cells to γc-/- DC was not 
further affected by IL-15Rα blockade (p≤0.01, Figure 1F and 
Figure S3C). The observed differences in T cell proliferation 
were not attributable to differential post-activation T cell viability 
(Figure S3D), or IL-15Rα expression, as both total and surface 
levels of IL-15Rα were comparable between WT and γc-/- DC 
(Figure 1G). Levels of total and surface IL-15 available for 
transpresentation were also unaffected by absence of DC-γc 
(Figure S3E).
To more definitely establish whether γc expression in DC was 
necessary for IL-15 trans-signaling to T cells, we transfected 
γc-/- DC with constructs encoding either GFP alone, the full-length 
γc fused to GFP38 (γcWT-GFP), or a truncated γc (γcΔc-GFP), that 
lacks 77 amino acids at the cytoplasmic carboxy-terminus, allow-
ing surface expression but not signaling function39 (Figure 1H and 
Figure S3F,G). Expression of γcWT-GFP or γcΔc-GFP in γc-/- DC 
rescued STAT5 activation in OTII T cells, while expression of 
GFP alone had no effect (Figure 1I and Figure S3H). Similar 
levels of GFP expression (≈35%) were obtained with all 
constructs (Figure S3I).
To confirm that IL-15 trans-presentation at the CD4+ T cell IS 
requires MHC:TCR engagement, we employed glass-supported 
planar lipid bilayers containing ICAM-1, CD80 and pOVA/I-
Ab to recapitulate the essential features of an antigen-presenting 
surface suitable for naïve T cell stimulation, and incorporated 
IL-15/IL-15Rα complexes to mimic DC-mediated IL-15 transp-
resentation. Using this model system, we measured STAT5 phos-
phorylation as a marker of IL-2Rβ/γc mediated trans-signaling at 
the T cell IS by TIRFM. As expected, naïve OTII T cells formed 
a mature IS, at which TCR accumulated in a central supramolecu-
lar cluster (cSMAC)39, only in response to pOVA/I-Ab (Figure 2A, 
arrows). In keeping with our flow-cytometry results, IL-15/
IL-15Rα did not activate STAT5 signaling in the absence of 
antigen, suggesting that TCR engagement is required for IL-15/ 
IL-15Rα mediated trans-signaling in CD4+ T cells (Figure 2A,B 
and Figure S4A,B). Despite dependence on TCR engagement for 
IL-15/IL-15Rα mediated STAT5 activation, PLCγ1 phosphoryla-
tion, which occurs downstream of TCR/CD28 signaling, and Akt 
phosphorylation, which is strongly induced by CD28 ligation, 
were not affected by IL-15 trans-signaling (Figure S5A–D). 
Similarly, Zap-70 phosphorylation following TCR triggering was 
not affected by IL-15 trans-signaling, indicating minimal cross-
talk between TCR/CD28 signals and the JAK/STAT pathway 
(Figure S5E–G).
Taken together, these data demonstrate that DC transpresent 
IL-15 to CD4+ T cells by a mechanism that depends on MHCII/
TCR ligation and DC-expressed γc. Surprisingly, γc signaling in 
DC was not required for IL-15 transpresentation, suggesting that 
γc facilitates IL-15 transpresentation through induced intermo-
lecular cis interactions and/or cytoskeletal reorganization at the 
intramembrane or ectodomain level.
Figure 2. IL-15 mediated trans-signaling in CD4+ T cells requires TCR engagement. (A) Representative TIRFM images of CD4+ T 
cells incubated on glass-supported planar bilayers containing ICAM-1, CD80, OVA323-339/I-A
b and IL-15/IL-15Rα, as indicated. After 30 min 
incubation at 37°C in HBS/HSA buffer, cells were fixed and stained for TCR (red, Alexa Fluor 568) and phospho-STAT5 (pSTAT5) (green, Alexa 
Fluor 488) in PBS buffer. White arrows in the image panels indicate central accumulation of TCR at the T cells IS. (B) Quantification of pSTAT5 
fluorescence in A. Data are presented as percentage increase in pSTAT5 fluorescence, relative to unstimulated controls. Data are from 2 
independent experiments (N=32-57) (mean ± S.E.M). P values, one-way ANOVA. Imaging was performed on a Nikon Ti microscope with a 
100x TIRF objective, N.A. 1.49, controlled by Nikon Elements software. Fluorescence images were captured using an Ixon cooled EMCCD 
camera (512 x 512 pixels, Andor Technology). Mean fluorescence intensity at contact interfaces was quantified from 14 bit images using 
Metamorph software. Brightness and contrast are adjusted uniformly across image groups for clarity.
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Binding-induced clustering and accumulation of MHCII at 
the DC IS
To investigate molecular events that follow MHC ligation at 
the DC IS at high spatial resolution, we developed a glass- 
supported bilayer system that recapitulates both adhesive and 
MHC-binding properties of the T cell surface (Figure 3A). To 
ligate ICAM-1 on DC, we loaded bilayers with a C-terminally 6 
histidine tagged inserted domain fragment of the LFA-1 α-subunit 
(αI) that is covalently locked in its high affinity conformation40. 
To ligate MHCII, we generated C-terminally monobiotinylated 
Fab’ fragments41 of an I-A/E specific monoclonal antibody (clone 
M5/114) to approximate TCR ectodomain size and valency (see 
Supplementary methods). These surrogate TCRs were attached 
to bilayers containing biotin headgroups via a streptavidin 
‘bridge’, ensuring a uniform orientation that is favourable for 
MHC binding. Fragments were labelled with fluorophores 
(f/p~3) to follow their recruitment and lateral reorganization 
upon binding to MHCII at the DC contact interface by confocal 
and TIRF microscopy.
Initial imaging by confocal microscopy revealed that WT DC 
exhibit a ‘crawling’ motility (mean velocity ~8 μm/min) on 
bilayers containing LFA-1 (Movie S1, Figure S6A,C). Ligation 
of MHCII on WT DC led to an arrest in motility (mean velocity 
~2.5 μm/min) and accumulation of engaged MHCII at the 
DC-bilayer interface (Movie S2, Figure S6A,C). Although γc-/- 
DC migrated more slowly (mean velocity ~6 μm/min) compared 
to WT DC, ligation of MHCII led to a similar arrest in motility 
(Movie S3, Figure S6B,D), indicating that MHCII ligation 
delivers a ‘stop’ signal to DCs, analogous to that in T cells 
following antigen recognition42, that is not dependent on DC-γc 
expression. MHC II ligation does not lead to a rise in intracellular 
Ca2+ levels in WT and γc-/- DC (Movie S4,5 and Figure S6E–G), 
suggesting that, in contrast to antigen-induced T cell stopping, 
motility arrest following MHC II ligation in DC is not associated 
with Ca2+ signaling.
We next investigated the binding-induced organization of 
MHC II at the DC IS by total internal reflection fluorescence 
microscopy (TIRFM). Within seconds of contact with bilayers, 
ligated MHCII formed small clusters throughout the contact 
interface (Figure 3B and Figure S6H), which were transported 
towards the center of the contact interface, presumably by interac-
tion with the DC cytoskeleton24 (Movie S6,7). The extent of MHC 
accumulation at the contact interface was similar to that of WT 
DC (Figure S6H,I).
DC-expressed γc controls IL-15Rα recruitment to the IS
Mirroring MHC polarisation to the IS43,44, γcWT-GFP and 
γcΔc-GFP expressed in γc-/- DC were recruited to the contact inter-
face, leading to ~4-fold enrichment of mean GFP fluorescence 
over 23 minutes (Figure 3B,E and 3C,F). In contrast, GFP alone 
was not enriched at the contact interface over the same time 
course (Figure 3D,G).
Since DC-expressed γc was critical for effective IL-15 transp-
resentation in co-culture assays, its recruitment and colocali-
zation with MHCII at the DC IS suggested the possibility of a 
spatially regulated mechanism for transpresentation, in which 
γc coordinates recruitment of IL-15/IL-15Rα to the DC synapse 
following MHCII ligation. To test this hypothesis, we imaged 
WT DC on bilayers at an early time-point (15 minutes), in the 
presence or absence of surrogate TCRs (anti-I-A/E Fab’), and 
labelled IL-15Rα for TIRF imaging. When compared to bilayers 
containing only LFA-1 αI domain, ligation of MHCII induced 
almost 3-fold more IL-15Rα at the DC IS, demonstrating that 
MHCII engagement is sufficient to recruit IL-15Rα to the IS in 
WT DC (Figure 4A,B). Strikingly, MHCII-induced IL-15Rα 
recruitment to the IS was severely compromised in γc-/- DC 
(p≤0.001, Figure 4A,B) while MHCII accumulation was relatively 
unaffected (Figure 4C). These differences were not accounted 
for by variations in TIRF imaging conditions between samples 
(Figure S7). The extent of colocalization between MHCII and 
IL-15Rα was also decreased in the absence of γc, suggesting 
that it promoted a closer association between engaged MHCII and 
IL-15Rα (Figure 4D and Figure S8). Expression of γcWT-GFP and 
γcΔc-GFP in γc-/- DC also resulted in ~70% increase in IL-15Rα 
accumulation at the interface upon MHC II ligation, when 
compared to expression of GFP alone (Figure 5A,B), indicating 
that γc signaling in DC was dispensable for IL-15Rα recruitment.
Discussion
Patients with γc-deficient SCID remain susceptible to opportunis-
tic HPV infections even when T cell function is restored by BMT. 
This raises the possibility that residual γc-deficient DC, which 
persist in the absence of myeloablative conditioning, might be 
ineffective in priming T cell immunity. To investigate this in a 
tractable model, we tested the ability of bone-marrow derived 
DC from γc knockout mice to activate normal naïve CD4+ 
T cells. We have identified defects in the ability of γc-deficient 
DC to activate antigen-specific CD4+ T cells, which could not 
be accounted for by a problem with DC maturation or antigen 
processing. Instead, our studies have revealed an unexpected 
requirement for IL-15 transpresentation in CD4+ T cell activation. 
Furthermore, we have identified a role for DC γc in the recruit-
ment of IL-15Rα to the DC side of the immune synapse, which 
is critical for effective IL-15 transpresentation to CD4+ T cells, 
and is independent of γc signaling function. Therefore, our in vitro 
functional and imaging studies have revealed a mechanism that 
may account for a subset of immune dysfunction in γc-deficient 
myeloid cells. While these studies have generated new hypoth-
eses that can be explored further in human DC, the finding that 
IL-15 transpresentation contributes to CD4+ T cell activation 
in a DC γc-dependent manner, extends our understanding of 
the costimulatory requirements for CD4+ T cell priming. High 
resolution imaging of DC using a planar bilayer model system 
has provided new perspectives on the active role of DC in IS 
formation, that we expect will be useful for further investigation 
of the DC IS.
Soluble IL-15 produced in DC binds effectively irrevers-
ibly (KD ~10-11 M)45 to co-expressed IL-15Rα within intracellular 
compartments, before trafficking to the DC cell surface, for 
transpresentation to T and NK cells expressing IL-2Rβ/γc 
heterodimers46,47. Signal transduction in T cells occurs through 
the cytoplasmic portions of IL-2Rβ/γc heterodimers, which are 
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Figure 3. γc is recruited with MHCII at the DC IS. (A) Schematic diagram of a glass-supported planar bilayer recapitulating a T cell surface. 
(B–D) Representative TIRFM images demonstrating GFP (green) and MHCII (red, Alexa Fluor 568) accumulation over time at the contact 
interface of LPS/OVA stimulated γc-/- DC expressing γcWT-GFP (B), γcΔc-GFP (C) or GFP alone (D), interacting on bilayers shown in A. (E–G) 
Time course of GFP accumulation at the contact interface in DC transfected with γcWT-GFP (E)(N=6), γcΔc-GFP (F)(N=5) or GFP alone (G)(N=5). 
Data represent mean fluorescence intensity (mean+S.E.M. are shown for clarity), normalized relative to values at initial point of contact by DC 
on bilayers (t=0). Live cells in HBS/HSA buffer were imaged in FCS2 flow chambers (Bioptechs) maintained at 37°C. Imaging was performed 
on a Nikon Ti microscope with a 100x TIRF objective, N.A. 1.49, controlled by Nikon Elements software. Fluorescence images were captured 
using an Ixon cooled EMCCD camera (512 x 512 pixels, Andor Technology). Mean fluorescence intensity at contact interfaces was quantified 
from 14 bit images using Metamorph software. Brightness and contrast are adjusted uniformly across image groups for clarity.
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Figure 4. IL-15Rα is recruited to the DC interface and colocalizes with engaged MHCII. LPS/OVA stimulated DC were incubated on glass-
supported planar bilayers containing LFA-1 αI ± I-A/E Fab’. After 15 min incubation at 37°C in HBS/HSA buffer, cells were fixed, permeabilized 
and stained for IL-15Rα (Alexa Fluor 488) in PBS buffer. (A) Representative TIRFM images showing IL-15Rα and MHCII (Alexa Fluor 568) 
accumulation at contact interfaces. Fluorescence intensity profiles (right panels) indicate the distribution of IL-15Rα (green) and MHCII (red) 
along the dashed white lines (merge). (B,C) Quantification in arbitrary units (AU) of mean IL-15Rα fluorescence (B) and MHCII fluorescence 
(C) at DC contact interfaces shown in A (N=89-90, mean ± S.E.M). (D) Quantification of colocalization between MHCII and IL-15Rα at DC 
contact interfaces (A), calculated as Pearson’s correlation coefficient (PCC). Imaging was performed on a Nikon Ti microscope with a 100x 
TIRF objective, N.A. 1.49, controlled by Nikon Elements software. Fluorescence images were captured using an Ixon cooled EMCCD camera 
(512 x 512 pixels, Andor Technology). Mean fluorescence intensity at contact interfaces was quantified from 14 bit images using Metamorph 
software. PCC was calculated for MHCII and IL-15Rα fluorescence channels using ImageJ software. Brightness and contrast are adjusted 
uniformly across image groups for clarity.
associated with Janus family tyrosine kinases JAK1 and JAK3. 
Assembly of the IL-15/IL-15R ternary complex in trans leads 
to activation of JAK1/3, and subsequent phosphorylation of 
IL-2Rβ/γc. This leads to recruitment and activation of signal 
transducer and activator of transcription 5 (STAT5) proteins12. We 
have shown in functional studies that IL-15 transpresentation by 
DC to CD4+ T cells is critically dependent on DC-expressed γc. 
Our imaging studies demonstrate that MHCII ligation leads to 
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Figure 5. γc is required for IL-15Rα recruitment to the DC IS. (A) Representative TIRFM images showing GFP, MHCII (Alexa Fluor 568) and 
IL-15Rα (Alexa Fluor 633) accumulation at contact interfaces of γc-/- DC, transfected with γcWT-GFP, γcΔc-GFP or ctrl GFP. (B) Quantification 
in arbitrary units (AU) of mean IL-15Rα fluorescence at contact interfaces shown in A (N=38-43, mean ± S.E.M). P values, one-way ANOVA. 
After incubation on bilayers at 37°C in HBS/HSA buffer, cells were fixed and permeabilized to stain for IL-15Rα in PBS buffer. Imaging was 
performed on a Nikon Ti microscope with a 100x TIRF objective, N.A. 1.49, controlled by Nikon Elements software. Fluorescence images were 
captured using an Ixon cooled EMCCD camera (512 x 512 pixels, Andor Technology). Mean fluorescence intensity at contact interfaces was 
quantified from 14 bit images using Metamorph software. Brightness and contrast are adjusted uniformly across image groups for clarity.
γc dependent recruitment of IL-15Rα to the DC IS, where it 
colocalizes with engaged MHCII. Both IL-15Rα recruitment to 
the DC IS, and IL-15 mediated trans-signaling in CD4+ T cells, 
are restored in γc-deficient DC following re-expression of γc. 
Neither process appeared to depend on signaling function as trun-
cation of the γc cytoplasmic tail was also effective in recruiting 
IL-15Rα. Curiously, transpresented IL-15 triggered STAT5 
signaling in CD4+ T cells only when TCR was engaged.
A precise picture of the molecular dynamics and subunit stoi-
chiometries, in cell membranes, of IL-15/IL-15Rα and its 
associated receptor subunits has not yet been established. 
However, elegant imaging studies of IL-15Rα in transformed 
and primary T cell lines have revealed considerable heterogene-
ity in subunit composition, and a far more diverse set of cis asso-
ciations, than might be predicted by ‘affinity conversion’ or other 
assembly models48. Of relevance to our findings, MHCII has 
been shown to associate with both IL-15Rα49 and with γc50. Our 
observations, that γc is recruited to the DC IS, plays a criti-
cal role in recruitment of IL-15Rα, and promotes greater 
colocalization between engaged MHCII and IL-15Rα, lead us to 
favor a molecular configuration on the DC cell surface in which 
IL-15Rα, γc, and MHCII exist as a loosely coupled molecular 
complex, that is consolidated by MHCII engagement. Since 
MHCII engagement leads to its clustering and dynamic 
transport, presumably by interaction with the DC cytoskeleton, 
MHCII-nucleated domains may serve as avidity-enhancing 
scaffolds, or platforms within liquid-ordered lipid domains51 that 
stabilize the IL-15Rα-γc-MHCII trimolecular association.
Taken together, our findings suggest a model of IL-15 transp-
resentation in which peptide/MHCII ligation by cognate TCR 
results in γc−mediated recruitment of IL-15Rα (in complex with 
IL-15) to the DC synapse, where it is positioned near sites of 
TCR engagement for binding in trans (Figure 6A,B). Coupled 
delivery of IL-15 mediated costimulation with antigen 
recognition is consistent with the suggestion that close membrane 
apposition at the DC-T cell interface, determined by the (small) 
size of pMHC/TCR and accessory receptor complexes (~15 nm), 
may favor assembly of the trans IL-15/IL-15R ternary complex 
at DC-T-cell interfaces, since it is similar in size to TCR/pMHC 
complexes52. TCR ligation of pMHC drives the formation of 
close contacts with APC, from which the large T cell surface 
phosphatase CD45, a key negative regulator of both TCR53, and 
γc cytokine receptor-associated JAK signaling54, is excluded35,55. 
Coupled (trans)presentation of pMHC and IL-15 at the DC-
T cell IS may therefore allow spatially coordinated activation 
of the biochemically distinct TCR and JAK/STAT signaling 
pathways during antigen-specific priming of naïve T cells by 
DC.
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Figure 6. Model of γc-facilitated IL-15/IL-15Rα transpresentation to CD4+ T cells. (A) In the absence of cognate peptide-MHC II (pMHCII), 
IL-2Rβ/γc cytokine receptor signaling in T cells is not initiated (open circles denote unphsophorylated IL-2Rβ/γc and associated JAK1/3), 
as these small receptors are likely positioned too far apart for stable binding of IL-15/IL-15Rα complexes on the DC surface. Inset depicts 
putative association of IL-15/IL-15Rα, MHCII and γc within liquid-ordered (Lo) lipid domains, and/or through cytoskeletal confinement. 
(B) Engagement of pMHCII on DC (1) leads to γc-dependent recruitment IL-15/IL-15Rα to the contact interface, close to regions of bound 
pMHCII (2); this would position IL-15/IL-15Rα complexes on the DC surface at a distance compatible with binding IL-2Rβ/γc receptors in 
trans (2). Close contacts also exclude CD45, allowing stable phosphorylation (red circles) of both TCR and IL-2Rβ/γc receptors, permitting 
recruitment and phosphorylation of STAT5 (3) in the context of productive antigen recognition.
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